SCHEMBL8305765

SCHEMBL8305765

Cc1ccc(N2CCNC2=O)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 3/20 0.43
HTT P42858 2/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
P2RX7 Q99572 1/20 0.42
G6PD P11413 1/20 0.41
MAPT P10636 2/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTR1A P08908 1/20 0.40
HTR3A P46098 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8306531 0.90 ALDH1A1 (0.51) NPSR1ALDH1A1HTTHSD17B10KDM4E
SCHEMBL7394860 0.83 MEN1 (0.49) HSD17B10HPGDMEN1KMT2AP2RX7
SCHEMBL8305437 0.83 MEN1 (0.41) ALDH1A1HTTHSD17B10KDM4EHPGD
SCHEMBL8305608 0.83 SCN9A (0.42) NPSR1ALDH1A1HTTHSD17B10KDM4E
SCHEMBL14502130 0.80 KDM4E (0.45) ALDH1A1HTTHSD17B10KDM4EHPGD
SCHEMBL8307179 0.79 HSD17B10 (0.44) NPSR1ALDH1A1HSD17B10P2RX7G6PD
SCHEMBL2882677 0.79 DDB1 (0.60) MEN1KMT2AP2RX7MAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL2366300 0.78 HTR1A (0.45) NPSR1ALDH1A1HSD17B10P2RX7G6PD
SCHEMBL24204354 0.77 CRBN (0.67) NPSR1ALDH1A1HTTHSD17B10KDM4E
SCHEMBL31607808 0.77 CRBN (0.67) NPSR1ALDH1A1HTTHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115581-A1 SUBSTITUTED PIPERIDINES AS CK1A DEGRADERS MONTE ROSA THERAPEUTICS AG (CH) 2025-04-10 US disclosed
WO-2023244817-A1 SUBSTITUTED PIPERIDINES AS CK1A DEGRADERS MONTE ROSA THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed
US-20070135428-A1 LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-14 US disclosed
US-20070135428-A1 LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-14 US disclosed
US-7205318-B2 Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-17 US disclosed
US-7205318-B2 Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-17 US disclosed
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250115581-A1 SUBSTITUTED PIPERIDINES AS CK1A DEGRADERS CKS1B, CSNK1A1, CKS2 NPSR1 2376/4885ALDH1A1 539/4885HTT 4116/4885
US-20070135428-A1 LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS F12, F2, PEPD NPSR1 2220/4885ALDH1A1 3204/4885HTT 4850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.